Kambiz Motamedi, MD

UCLA
Los Angeles, California, United States

Disclosure information not submitted.

Presentation(s):

• Paper 83 - PHASE 1 STUDY OF INTRATUMORAL BO-112 AND NIVOLUMAB IN RESECTABLE SOFT TISSUE SARCOMA UNDERGOING HYPOFRACTIONATED PREOPERATIVE RADIOTHERAPY

  Saturday, November 16, 2024
  10:30 AM – 12:00 PM PST